COHANCE LIFESCIENCES LTD (India) holds 71 active US FDA Type II Drug Master Files and 7 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 4 FDA-registered manufacturing sites. 10 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “COHANCE LIFESCIENCES LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/cohance-lifesciences-ltd

Overview

COHANCE LIFESCIENCES LTD is an active pharmaceutical ingredient (API) supplier with 63 active FDA Type II Drug Master Files, covering (S)-8-ETHYL-8-HYDROXY-2,3,5,8-TETRAHYDRO-6-OXA-3A-AZA-CYCLOPENTA[B]NAPHTHALENE-1,4,7-TRIONE (400012); 1-ACETAMIDO 3,5-DIMETHYL ADAMANTANE; 7-ETHYL-10-HYDROXYCAMPTOTHECIN; APIXABAN; ARIPIPRAZOLE USP; ATOMOXETINE HYDROCHLORIDE USP.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which COHANCE LIFESCIENCES LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

COHANCE LIFESCIENCES LTD holds 71 active (78 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • PROPAFENONE HYDROCHLORIDE USPActive2026-05-25
  • CAMPTOTHECINActive2026-05-08
  • PYRIDOSTIGMINE BROMIDE USPActive2026-03-18
  • IRINOTECAN HYDROCHLORIDE TRIHYDRATEActive2026-03-05
  • EXATECAN MESYLATEActive2026-01-23
  • CILOSTAZOLActive2025-12-03
  • HYDROXYZINE PAMOATE USPActive2025-11-04
  • BIS(TERT-BUTOXYCARBONYL) LISDEXAMFETAMINEActive2025-07-11
  • BUSPIRONE HYDROCHLORIDE USPActive2025-01-22
  • DESVENLAFAXINE SUCCINATEActive2024-11-20
  • MENTHADIENOLActive2024-09-28
  • OLIVETOLActive2024-09-27
  • 7-ETHYL-10-HYDROXYCAMPTOTHECINActive2024-09-09
  • (S)-8-ETHYL-8-HYDROXY-2,3,5,8-TETRAHYDRO-6-OXA-3A-AZA-CYCLOPENTA[B]NAPHTHALENE-1,4,7-TRIONE (400012)Active2023-10-20
  • EMPAGLIFLOZINActive2022-07-12
  • MARAVIROCActive2021-09-24
  • PROBENECID USPActive2021-08-04
  • PIRIBEDILActive2020-11-24
  • DAPSONE USPActive2020-10-30
  • EDETATE CALCIUM DISODIUM DIHYDRATE USPActive2020-10-01
  • APIXABANActive2020-07-02
  • MEXILETINE HYDROCHLORIDE USPActive2020-06-19
  • DIFLUNISAL USPActive2020-04-20
  • VENLAFAXINE HYDROCHLORIDE USPActive2020-01-11
  • TICAGRELORActive2019-12-31
  • HYDRALAZINE HYDROCHLORIDE USPActive2019-12-24
  • POSACONAZOLEActive2019-12-24
  • VERAPAMIL HYDROCHLORIDE USPActive2019-11-22
  • DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATEActive2019-10-15
  • CHLOROQUINE PHOSPHATE USPActive2019-09-20
  • GLYCOPYRRONIUM TOSYLATEActive2019-07-30
  • MIRABEGRONActive2019-04-26
  • 1-ACETAMIDO 3,5-DIMETHYL ADAMANTANEActive2019-03-29
  • FERRIC CITRATEActive2019-03-13
  • ENTACAPONE USPActive2018-12-13
  • BACLOFEN USPActive2018-11-09
  • ZONISAMIDE USPActive2018-10-09
  • ESLICARBAZEPINE ACETATEActive2018-08-09
  • TRIENTINE HYDROCHLORIDEActive2018-07-19
  • PIRFENIDONEActive2017-10-28
  • QUETIAPINE FUMARATE USPActive2017-10-03
  • RIVAROXABANActive2017-10-02
  • CLOZAPINE USPActive2017-08-24
  • LURASIDONE HYDROCHLORIDEActive2017-06-06
  • ZONISAMIDE USPActive2017-01-04
  • ARIPIPRAZOLE USPActive2015-12-14
  • GLYCOPYRROLATE USPActive2015-11-30
  • DIPYRIDAMOLE USPActive2015-09-04
  • FLUVOXAMINE MALEATE USPActive2015-07-22
  • ATOMOXETINE HYDROCHLORIDE USPActive2015-03-26

Showing the 50 most relevant of 78 Drug Master Files (active first). The full list is in the FDA DMF list.

Registered manufacturing sites (4)

Physical sites registered with the US FDA and resolved to COHANCE LIFESCIENCES LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

10 FDA enforcement records linked to this company.

  • warning_letter2026-01-30

    FDA Warning Letter (drug product)

  • 4832024-07-12

    Computer control of master formula records

  • 4832024-07-12

    Records not made readily available to FDA

  • 4832019-08-20

    Equipment Design, Size and Location

  • 4832019-08-20

    Approve or reject procedures or specs

  • 4832019-08-20

    Scientifically sound laboratory controls

  • 4832018-02-06

    Procedures not in writing, fully followed

  • 4832018-02-06

    Failure to meet specifications

  • 4832018-02-06

    Control procedures to monitor and validate performance

  • 4832018-02-06

    Written in-process control procedures

For suppliers

Is this COHANCE LIFESCIENCES LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.